Of particular note, while both ESR1 and PGR showed higher expression in non-recurrent tumours in the first 5 years of follow-up in METABRIC, neither showed a significant difference after 10 years in either METABRIC or VLR (Supplementary Figure 4A and B). This evidence concerns the gene ESR1 and neoplasm.